Evening Symposia Series

Attention-deficit/hyperactivity disorder (ADHD) remains an undertreated
and underrecognized disorder. Studies have shown that fewer than half
of all children and adolescents who met DSM-IV criteria for
ADHD had had a prior diagnosis, and fewer than a third of these had
received medication for ADHD for most of the previous 12 months. Among
adults, the situation is even worse, as the National Comorbidity Survey
Replication reported that only about 11% of adults with ADHD received
treatment for the disorder within the past 12 months. These data reinforce
the ongoing need to educate clinicians concerning the recognition
and treatment of ADHD in childhood, adolescence, and adulthood. This
evening symposium will discuss the diagnosis and treatment of ADHD,
with particular emphasis on the period from early adolescence to adulthood,
through didactic presentation and case vignettes
| Thursday, September 4, 2008 |
Westchester,
NY |
| Tuesday, September 9, 2008 |
Plantation, FL |
| Thursday, September 11, 2008 |
Pittsburgh, PA |
| Tuesday, September 16, 2008 |
Detroit, MI |
| Tuesday, September 23, 2008 |
Baltimore, MD |
| Thursday, September 25, 2008 |
Boston, MA |
| Thursday, October 2, 2008 |
Denver, CO |
| Wednesday, October 15, 2008 |
Huntington Beach, CA |
| Friday, October 17, 2008 |
New York, NY |
| Wednesday, November 5, 2008 |
Dallas, TX |
|
|
|
.
Telesymposia

The first telesymposium
series in this broad CME initiative, Focus on Diagnosis,
briefly reviews recent data on the epidemiology, neurobiology, and
prevalence of ADHD, along with common psychiatric comorbidities. The
activity then examines the assessment and diagnosis of ADHD in adolescents
and adults. This activity is chaired by Timothy E. Wilens, MD and
co-chaired by Thomas J. Spencer, MD.
The second
telesymposium, Focus on Treatment,
outlines pharmacologic and psychosocial treatment strategies for adolescent
and adult patients with ADHD. Data from recent clinical trials of
stimulant and nonstimulant medications will be examined for efficacy
and safety, and second-line, off-label use of medications in adolescents
and adults with ADHD will be discussed. This activity is chaired
by Timothy E. Wilens, MD and co-chaired by Jeffrey H. Newcorn, MD.
The third telesymposium,
Focus on Complex Patients,
offers a discussion of treatment strategies
and adjustments that may be necessary for adolescent and adult patients
with ADHD who do not respond to standard pharmacotherapy, are nonadherent
to treatment, or may need a more intensive individualized multimodal
approach. This activity is chaired by Timothy E. Wilens, MD.

Newsletters

Comprehensive
Care for Patients with ADHD: A Practical, Interactive Initiative,
Focus on Complex Patients
Volume 3, No. 1
The first of two newsletters edited by Dr Timothy Wilens, this roundtable
discussion on ADHD in adolescents and adults was designed to provide
physicians with expert opinion on the diagnosis and management of
difficult cases. Dr Wilens, the moderator for this discussion, was
joined by Drs Larry Culpepper and Margaret D. Weiss.
The
Changing Face of ADHD: Addressing Changing Symptoms,
Adjusting
Treatment Management. Volume 2, No. 2
This newsletter focuses on the available treatment options,
including proper titration and dosage of pharmacotherapies, as well
as on safety concerns in adolescents and young adults.
The
Changing Face of ADHD: Addressing Changing Symptoms,
Adjusting
Treatment Management. Volume 2, No. 1
The first of 2 newsletters edited by Timothy Wilens, MD,
focusing on the changing symptomatology in persistent ADHD and briefly
discussing treatment options.
The
Pharmacologic and Psychosocial Challenges of
Treating the Adolescent With ADHD
The first of 2 newsletters edited by Dr Joseph Biederman,
focusing on meeting the psychosocial needs of adolescents as they
move from childhood to adulthood.
The
Pharmacologic and Psychosocial Challenges of
Treating the Adolescent With ADHD
The second newsletter edited by Dr Joseph Biederman,
focusing on the physical changes that occur with maturation
and their relationship to medication selection and dosage.

Fireside Forum

The Fireside Forum series is designed to provide practicing clinicians
with an opportunity to participate in archived telesymposia containing
attendee-driven open-forum discussions with leading experts, Drs.
Timothy Wilens, Jeffrey Newcorn and James J. McGough
in the field of attention-deficit/hyperactivity disorder (ADHD).

On Demand

Comprehensive Care for Patients With ADHD: An On-Demand CME/CE - Certified Activity
This enduring On-Demand CME/CE Activity, derived from the Evening Symposium Series, will reinforce clinical knowledge for those who attended a symposium and provide a focused educational experience for first-time participants
Adolescent
and Adult ADHD: Meeting the Challenges of Changing Needs ? Web Symposium
An interactive symposium, with expert commentary by
Timothy E. Wilens, MD, and other national expert ADHD thought
leaders. This activity focuses on the presentation, diagnosis,
and treatment of adolescents with ADHD, with particular emphasis on
differential diagnosis and treatment of patients with co-occurring
psychiatric disorders.
Web
Cast
An interactive, archived Web cast, with expert commentary
by Joseph Biederman, MD and Timothy E. Wilens,
MD, addressing the diagnosis, symptom migration, and persistence
of the disease into adulthood..
Archived
Telesymposia
Two interactive telesymposia, with expert commentary by Joseph
Biederman, MD and Timothy E. Wilens, MD, examine treatment modalities
that will enhance the practicing psychiatristâs ability to provide
highly individualized care for adolescent patients with ADHD. Telesymposium
1 focuses on the psychosocial challenges of treating the adolescent
with ADHD. The companion telesymposium focuses on the pharmacologic
challenges.
